Peptide Stacks for Research: BPC-157, TB-500, and Beyond
Peptide Stacks for Research: BPC-157, TB-500, and Beyond Combining research peptides — commonly called “stacking” in the research community — is the practice of using two or more peptides simultaneously to target complementary or synergistic biological pathways. The rationale is straightforward: most biological processes involve multiple molecular actors operating in parallel, and a single compound […]
How to Reconstitute and Store Research Peptides: Complete 2026 Guide
How to Reconstitute and Store Research Peptides: Complete 2026 Guide Research peptides are supplied as lyophilized (freeze-dried) powder to maximize shelf stability during shipping and long-term storage. Before use in laboratory protocols, lyophilized peptides must be reconstituted into solution. This guide covers everything researchers need to know: solvent selection, concentration calculations, storage best practices, purity […]
Methylene Blue Research: Mechanism, Cognitive Applications & Science
Methylene Blue Research: Mechanism, Cognitive Applications & Science Methylene Blue (methylthioninium chloride; CAS 61-73-4) is the world’s oldest synthetic pharmaceutical — first synthesized by Heinrich Caro in 1876 and approved as the first synthetic drug by the FDA for methemoglobinemia. In 2026, it is also one of the fastest-growing research compounds in the nootropic and […]
IGF-1 LR3 Research Guide: Why the LR3 Modification Changes Everything
IGF-1 LR3 Research Guide: Why the LR3 Modification Changes Everything IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arg3) is a synthetic analog of human IGF-1 bearing two deliberate structural modifications that dramatically alter its pharmacokinetics: an arginine substitution at position 3 (replacing glutamic acid) and a 13-amino-acid N-terminal extension. CAS 946870-92-4. Molecular weight: approximately 9,117 Da. […]
Semax vs N-Acetyl-Semax vs Adamax: The Complete Nootropic Peptide Guide
Semax vs. N-Acetyl-Semax vs. Adamax: The Complete Nootropic Peptide Guide Semax, N-Acetyl-Semax, and Adamax represent three generations of the same foundational research peptide — each built on the heptapeptide sequence Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP) derived from the adrenocorticotropin hormone (ACTH) fragment 4-7. Each modification improves on the last in terms of enzymatic stability, CNS bioavailability, or receptor […]
BPC-157 Research Guide: Mechanism, Studies & Key Findings
BPC-157 Research Guide: Mechanism, Studies & Key Findings BPC-157 — Body Protection Compound-157 — is a synthetic pentadecapeptide (15 amino acids; CAS 137525-51-0) isolated from a partial sequence of a human gastric juice protein. With a molecular formula of C62H98N16O22 and molecular weight of 1419.53 g/mol, BPC-157 is one of the most extensively studied synthetic […]
What Is CagriSema? Cagrilintide + Semaglutide Research Guide 2026
What Is CagriSema? Cagrilintide + Semaglutide Research Guide 2026 CagriSema is Novo Nordisk’s investigational fixed-ratio co-formulation combining cagrilintide (a long-acting amylin analog; CAS 2219415-09-3) and semaglutide (GLP-1 receptor agonist; CAS 910463-68-2), currently in Phase 3 evaluation across the REDEFINE clinical program. Unlike retatrutide’s single-molecule triple agonism, CagriSema achieves dual-pathway receptor engagement by combining two distinct […]
MOTS-C: The Mitochondrial Peptide at the Center of Longevity Research
MOTS-C: The Mitochondrial Peptide at the Center of Longevity Research MOTS-C (Mitochondrial Open reading frame of the twelve S rRNA type-C) is a 16-amino-acid bioactive peptide — sequence: MRWQEMGYIFYPRKLR — encoded not by nuclear DNA, but by the mitochondrial genome, specifically within the 12S ribosomal RNA region. CAS 1627580-76-4. This makes MOTS-C one of a […]
What Is Retatrutide (GLP-3)? The Triple-Agonist Research Guide 2026
What Is Retatrutide (GLP-3)? The Triple-Agonist Research Guide 2026 Retatrutide — also called GLP-3, LY-3437943, and NOP2Y096GV — is a synthetic peptide research compound developed by Eli Lilly that simultaneously activates three receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR). This triple-agonist profile places retatrutide in […]
GLP-1 vs GLP-2 vs GLP-3: What’s the Difference? (2026 Research Guide)
GLP-1 vs. GLP-2 vs. GLP-3: What’s the Difference? (2026 Research Guide) The terms GLP-1, GLP-2, and GLP-3 appear across research literature, clinical trial databases, and peptide vendor catalogs — but they refer to fundamentally different compounds with different receptors, different mechanisms, and entirely different research applications. This guide breaks down each one clearly so researchers […]